In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

Three Motley Fool contributors think they've found ideal dividend growth stocks to buy and hold -- and all three are ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...

This paper studies a fixed-time output tracking control problem of non-smooth cyber-physical systems (CPSs) subject to injection/deception attacks and performance constraints.

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Touro University Nevada is asking for volunteers to take part in a study on the long-term effects on brain health from injectable weight-loss or diabetic medication, such as Ozempic.The university's ...

Massachusetts health insurers are effectively telling the drug companies that they may seek a rapidly growing customer base ...